Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →21
🟡 Moderate
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
18,227
Total Claims
$1.4M
Drug Cost
1,727
Beneficiaries
$794
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 1,498 Interventional Pain Management providers
+38%
Opioid rate vs peers
63.3% vs 45.9% avg
+65%
Cost per patient vs peers
$794 vs $483 avg
+13%
Brand preference vs peers
4.6% vs 4.1% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
63.3%
Opioid Rate
11,540
Opioid Claims
$771K
Opioid Cost
18.9%
Long-Acting Rate
This provider's opioid prescribing rate of 63.3% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 847 claims · $603K
Generic: 17,369 claims · $762K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Oxycodone Hcl/Acetaminophen | 3,524 | $160K |
| Hydrocodone/Acetaminophen | 3,385 | $104K |
| Oxycodone Myristate | 234 | $104K |
| Oxycodone Hcl/Acetaminophen | 23 | $93K |
| Buprenorphine Hcl/Naloxone Hcl | 349 | $70K |
| Buprenorphine | 252 | $69K |
| Abaloparatide | 23 | $65K |
| Erenumab-Aooe | 37 | $54K |
| Onabotulinumtoxina | 42 | $54K |
| Oxycodone Hcl | 123 | $51K |
| Romosozumab-Aqqg | 17 | $42K |
| Tapentadol Hcl | 20 | $31K |
| Buprenorphine Hcl | 34 | $27K |
| Gabapentin | 1,426 | $26K |
| Fentanyl | 290 | $25K |
Prescribing Profile
60
Unique Drugs
21.0
Anomaly Score
Patient Profile
70
Avg Age
61%
Female
1.70
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About